Table 1 Baseline characteristics of intervention group (L-carnitine) and control group (placebo)
Parameters | L-carnitine (n = 30), mean ± SD | Placebo (n = 30), mean ± SD | p-value1 |
|---|---|---|---|
Age (year) | 52.83 ± 17.71 | 53.33 ± 16.99 | 0.912 |
Sex | |||
    Male | 20 (66.7%) | 22 (73.3%) | 0.573 |
    Female | 10 (33.3%) | 8 (26.7%) | |
Height (cm) | 169.03 ± 4.95 | 169.79 ± 4.69 | 0.545 |
Weight (kg) | 69.22 ± 17.46 | 67.41 ± 13.39 | 0.654 |
BMI (kg/m2) | 24.16 ± 5.69 | 23.36 ± 4.32 | 0.545 |
GCS | 6.53 ± 2.54 | 7.27 ± 2.54 | 0.269 |
Heart rate | 98.03 ± 19.36 | 94.83 ± 23.07 | 0.563 |
Respiratory rate | 19.83 ± 5.17 | 22.80 ± 15.09 | 0.313 |
Calf circumference (cm) | 32.67 ± 4.67 | 32.47 ± 3.93 | 0.858 |
MAC (cm) | 32.10 ± 4.99 | 31.17 ± 4.15 | 0.434 |
Ulna (cm) | 26.87 ± 2.22 | 27.10 ± 2.41 | 0.698 |
SOFA | 6.23 ± 2.37 | 7.13 ± 2.62 | 0.169 |
qSOFA | 1.27 ± 0.45 | 1.50 ± 0.51 | 0.065 |
APACHE II | 18.50 ± 5.48 | 17.37 ± 4.71 | 0.394 |
Nutric score | 3.93 ± 2.05 | 4.03 ± 1.83 | 0.843 |
The primary site of infection | |||
    Respiratory | 15 (50.00%) | 20 (66.70%) | 0.190 |
    Urinary | 5 (16.70%) | 3 (10.00%) | 0.448 |
    Bloodstream | 3 (10.00%) | 3 (10.00%) | 0.999 |
    Abdominal | 3 (10.00%) | 1 (3.30%) | 0.301 |
    Other | 4 (13.30%) | 3 (10.00%) | 0.688 |